Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-24 · accession 0000950170-25-098339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-24 | 2025-07-24 | KMTS | COHEN RAYMOND W | Dir | A - Grant | — | +13.0K | 13.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-07-24 | A | A | 12,994 | — | 12,994 | D | — | — | (F1) The Reporting Person previously held restricted Class A Common Units of West Affum Holdings, L.P. granted on July 24, 2024, which were automatically converted into 12,994 restricted common shares of the Issuer in connection with the Issuer's initial public offering. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares held by the Reporting Person vested on July 24, 2025. Of the remaining restricted common shares held by the Reporting Person, 4,331 restricted common shares will vest on July 24, 2026 and 4,332 restricted common shares will vest on July 24, 2027. |